The global market for Risperidone was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Risperidone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Risperidone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Risperidone include Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma, Apotex, Celltrion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Risperidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Risperidone.

The Risperidone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Risperidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Risperidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Risperidone Market Report

Report Metric	Details
Report Name	Risperidone Market
Segment by Type	Tablet Oral Solution
Segment by Application	Schizophrenia Bipolar Disorder
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma, Apotex, Celltrion, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, Luye Pharma Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Risperidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Risperidone Market report?

Ans: The main players in the Risperidone Market are Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma, Apotex, Celltrion, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, Luye Pharma Group

What are the Application segmentation covered in the Risperidone Market report?

Ans: The Applications covered in the Risperidone Market report are Schizophrenia, Bipolar Disorder

What are the Type segmentation covered in the Risperidone Market report?

Ans: The Types covered in the Risperidone Market report are Tablet, Oral Solution

1 Risperidone Market Overview

1.1 Product Definition

1.2 Risperidone by Type

1.2.1 Global Risperidone Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tablet

1.2.3 Oral Solution

1.3 Risperidone by Application

1.3.1 Global Risperidone Market Value by Application (2024 VS 2031)

1.3.2 Schizophrenia

1.3.3 Bipolar Disorder

1.4 Global Risperidone Market Size Estimates and Forecasts

1.4.1 Global Risperidone Revenue 2020-2031

1.4.2 Global Risperidone Sales 2020-2031

1.4.3 Global Risperidone Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Risperidone Market Competition by Manufacturers

2.1 Global Risperidone Sales Market Share by Manufacturers (2020-2025)

2.2 Global Risperidone Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Risperidone Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Risperidone, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Risperidone, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Risperidone, Product Type & Application

2.7 Global Key Manufacturers of Risperidone, Date of Enter into This Industry

2.8 Global Risperidone Market Competitive Situation and Trends

2.8.1 Global Risperidone Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Risperidone Players Market Share by Revenue

2.8.3 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Risperidone Market Scenario by Region

3.1 Global Risperidone Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Risperidone Sales by Region: 2020-2031

3.2.1 Global Risperidone Sales by Region: 2020-2025

3.2.2 Global Risperidone Sales by Region: 2026-2031

3.3 Global Risperidone Revenue by Region: 2020-2031

3.3.1 Global Risperidone Revenue by Region: 2020-2025

3.3.2 Global Risperidone Revenue by Region: 2026-2031

3.4 North America Risperidone Market Facts & Figures by Country

3.4.1 North America Risperidone Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Risperidone Sales by Country (2020-2031)

3.4.3 North America Risperidone Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Risperidone Market Facts & Figures by Country

3.5.1 Europe Risperidone Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Risperidone Sales by Country (2020-2031)

3.5.3 Europe Risperidone Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Risperidone Market Facts & Figures by Region

3.6.1 Asia Pacific Risperidone Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Risperidone Sales by Region (2020-2031)

3.6.3 Asia Pacific Risperidone Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Risperidone Market Facts & Figures by Country

3.7.1 Latin America Risperidone Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Risperidone Sales by Country (2020-2031)

3.7.3 Latin America Risperidone Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Risperidone Market Facts & Figures by Country

3.8.1 Middle East and Africa Risperidone Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Risperidone Sales by Country (2020-2031)

3.8.3 Middle East and Africa Risperidone Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Risperidone Sales by Type (2020-2031)

4.1.1 Global Risperidone Sales by Type (2020-2025)

4.1.2 Global Risperidone Sales by Type (2026-2031)

4.1.3 Global Risperidone Sales Market Share by Type (2020-2031)

4.2 Global Risperidone Revenue by Type (2020-2031)

4.2.1 Global Risperidone Revenue by Type (2020-2025)

4.2.2 Global Risperidone Revenue by Type (2026-2031)

4.2.3 Global Risperidone Revenue Market Share by Type (2020-2031)

4.3 Global Risperidone Price by Type (2020-2031)

5 Segment by Application

5.1 Global Risperidone Sales by Application (2020-2031)

5.1.1 Global Risperidone Sales by Application (2020-2025)

5.1.2 Global Risperidone Sales by Application (2026-2031)

5.1.3 Global Risperidone Sales Market Share by Application (2020-2031)

5.2 Global Risperidone Revenue by Application (2020-2031)

5.2.1 Global Risperidone Revenue by Application (2020-2025)

5.2.2 Global Risperidone Revenue by Application (2026-2031)

5.2.3 Global Risperidone Revenue Market Share by Application (2020-2031)

5.3 Global Risperidone Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Janssen (Johnson & Johnson)

6.1.1 Janssen (Johnson & Johnson) Company Information

6.1.2 Janssen (Johnson & Johnson) Description and Business Overview

6.1.3 Janssen (Johnson & Johnson) Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Janssen (Johnson & Johnson) Risperidone Product Portfolio

6.1.5 Janssen (Johnson & Johnson) Recent Developments/Updates

6.2 Ajanta Pharma

6.2.1 Ajanta Pharma Company Information

6.2.2 Ajanta Pharma Description and Business Overview

6.2.3 Ajanta Pharma Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Ajanta Pharma Risperidone Product Portfolio

6.2.5 Ajanta Pharma Recent Developments/Updates

6.3 Amneal Pharmaceuticals

6.3.1 Amneal Pharmaceuticals Company Information

6.3.2 Amneal Pharmaceuticals Description and Business Overview

6.3.3 Amneal Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Amneal Pharmaceuticals Risperidone Product Portfolio

6.3.5 Amneal Pharmaceuticals Recent Developments/Updates

6.4 Aurobindo Pharma

6.4.1 Aurobindo Pharma Company Information

6.4.2 Aurobindo Pharma Description and Business Overview

6.4.3 Aurobindo Pharma Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Aurobindo Pharma Risperidone Product Portfolio

6.4.5 Aurobindo Pharma Recent Developments/Updates

6.5 Hikma

6.5.1 Hikma Company Information

6.5.2 Hikma Description and Business Overview

6.5.3 Hikma Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Hikma Risperidone Product Portfolio

6.5.5 Hikma Recent Developments/Updates

6.6 Sandoz

6.6.1 Sandoz Company Information

6.6.2 Sandoz Description and Business Overview

6.6.3 Sandoz Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sandoz Risperidone Product Portfolio

6.6.5 Sandoz Recent Developments/Updates

6.7 Lannett

6.7.1 Lannett Company Information

6.7.2 Lannett Description and Business Overview

6.7.3 Lannett Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Lannett Risperidone Product Portfolio

6.7.5 Lannett Recent Developments/Updates

6.8 Tris Pharma

6.8.1 Tris Pharma Company Information

6.8.2 Tris Pharma Description and Business Overview

6.8.3 Tris Pharma Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Tris Pharma Risperidone Product Portfolio

6.8.5 Tris Pharma Recent Developments/Updates

6.9 Apotex

6.9.1 Apotex Company Information

6.9.2 Apotex Description and Business Overview

6.9.3 Apotex Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Apotex Risperidone Product Portfolio

6.9.5 Apotex Recent Developments/Updates

6.10 Celltrion

6.10.1 Celltrion Company Information

6.10.2 Celltrion Description and Business Overview

6.10.3 Celltrion Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Celltrion Risperidone Product Portfolio

6.10.5 Celltrion Recent Developments/Updates

6.11 Dr. Reddy's Laboratories

6.11.1 Dr. Reddy's Laboratories Company Information

6.11.2 Dr. Reddy's Laboratories Description and Business Overview

6.11.3 Dr. Reddy's Laboratories Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Dr. Reddy's Laboratories Risperidone Product Portfolio

6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.12 Torrent Pharmaceuticals

6.12.1 Torrent Pharmaceuticals Company Information

6.12.2 Torrent Pharmaceuticals Description and Business Overview

6.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Torrent Pharmaceuticals Risperidone Product Portfolio

6.12.5 Torrent Pharmaceuticals Recent Developments/Updates

6.13 Luye Pharma Group

6.13.1 Luye Pharma Group Company Information

6.13.2 Luye Pharma Group Description and Business Overview

6.13.3 Luye Pharma Group Risperidone Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Luye Pharma Group Risperidone Product Portfolio

6.13.5 Luye Pharma Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Risperidone Industry Chain Analysis

7.2 Risperidone Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Risperidone Production Mode & Process Analysis

7.4 Risperidone Sales and Marketing

7.4.1 Risperidone Sales Channels

7.4.2 Risperidone Distributors

7.5 Risperidone Customer Analysis

8 Risperidone Market Dynamics

8.1 Risperidone Industry Trends

8.2 Risperidone Market Drivers

8.3 Risperidone Market Challenges

8.4 Risperidone Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Janssen Pharmaceutica

Aurobindo

Hikma

Aurobindo Pharma

Amneal Pharmaceuticals

Janssen (Johnson& Johnson)

Dr. Reddy’s Laboratories

Torrent Pharmaceuticals

Luye Pharma Group

List of Tables

Table 1. Global Risperidone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Risperidone Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Risperidone Market Competitive Situation by Manufacturers in 2024

Table 4. Global Risperidone Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Risperidone Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Risperidone Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Risperidone Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Risperidone Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Risperidone, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Risperidone, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Risperidone, Product Type & Application

Table 12. Global Key Manufacturers of Risperidone, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Risperidone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Risperidone Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Risperidone Sales Market Share by Region (2020-2025)

Table 19. Global Risperidone Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Risperidone Sales Market Share by Region (2026-2031)

Table 21. Global Risperidone Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Risperidone Revenue Market Share by Region (2020-2025)

Table 23. Global Risperidone Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Risperidone Revenue Market Share by Region (2026-2031)

Table 25. North America Risperidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Risperidone Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Risperidone Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Risperidone Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Risperidone Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Risperidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Risperidone Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Risperidone Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Risperidone Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Risperidone Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Risperidone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Risperidone Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Risperidone Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Risperidone Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Risperidone Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Risperidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Risperidone Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Risperidone Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Risperidone Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Risperidone Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Risperidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Risperidone Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Risperidone Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Risperidone Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Risperidone Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Risperidone Sales (K Pcs) by Type (2020-2025)

Table 51. Global Risperidone Sales (K Pcs) by Type (2026-2031)

Table 52. Global Risperidone Sales Market Share by Type (2020-2025)

Table 53. Global Risperidone Sales Market Share by Type (2026-2031)

Table 54. Global Risperidone Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Risperidone Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Risperidone Revenue Market Share by Type (2020-2025)

Table 57. Global Risperidone Revenue Market Share by Type (2026-2031)

Table 58. Global Risperidone Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Risperidone Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Risperidone Sales (K Pcs) by Application (2020-2025)

Table 61. Global Risperidone Sales (K Pcs) by Application (2026-2031)

Table 62. Global Risperidone Sales Market Share by Application (2020-2025)

Table 63. Global Risperidone Sales Market Share by Application (2026-2031)

Table 64. Global Risperidone Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Risperidone Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Risperidone Revenue Market Share by Application (2020-2025)

Table 67. Global Risperidone Revenue Market Share by Application (2026-2031)

Table 68. Global Risperidone Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Risperidone Price (USD/Pcs) by Application (2026-2031)

Table 70. Janssen (Johnson & Johnson) Company Information

Table 71. Janssen (Johnson & Johnson) Description and Business Overview

Table 72. Janssen (Johnson & Johnson) Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Janssen (Johnson & Johnson) Risperidone Product

Table 74. Janssen (Johnson & Johnson) Recent Developments/Updates

Table 75. Ajanta Pharma Company Information

Table 76. Ajanta Pharma Description and Business Overview

Table 77. Ajanta Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Ajanta Pharma Risperidone Product

Table 79. Ajanta Pharma Recent Developments/Updates

Table 80. Amneal Pharmaceuticals Company Information

Table 81. Amneal Pharmaceuticals Description and Business Overview

Table 82. Amneal Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Amneal Pharmaceuticals Risperidone Product

Table 84. Amneal Pharmaceuticals Recent Developments/Updates

Table 85. Aurobindo Pharma Company Information

Table 86. Aurobindo Pharma Description and Business Overview

Table 87. Aurobindo Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Aurobindo Pharma Risperidone Product

Table 89. Aurobindo Pharma Recent Developments/Updates

Table 90. Hikma Company Information

Table 91. Hikma Description and Business Overview

Table 92. Hikma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Hikma Risperidone Product

Table 94. Hikma Recent Developments/Updates

Table 95. Sandoz Company Information

Table 96. Sandoz Description and Business Overview

Table 97. Sandoz Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Sandoz Risperidone Product

Table 99. Sandoz Recent Developments/Updates

Table 100. Lannett Company Information

Table 101. Lannett Description and Business Overview

Table 102. Lannett Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Lannett Risperidone Product

Table 104. Lannett Recent Developments/Updates

Table 105. Tris Pharma Company Information

Table 106. Tris Pharma Description and Business Overview

Table 107. Tris Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Tris Pharma Risperidone Product

Table 109. Tris Pharma Recent Developments/Updates

Table 110. Apotex Company Information

Table 111. Apotex Description and Business Overview

Table 112. Apotex Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. Apotex Risperidone Product

Table 114. Apotex Recent Developments/Updates

Table 115. Celltrion Company Information

Table 116. Celltrion Description and Business Overview

Table 117. Celltrion Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. Celltrion Risperidone Product

Table 119. Celltrion Recent Developments/Updates

Table 120. Dr. Reddy's Laboratories Company Information

Table 121. Dr. Reddy's Laboratories Description and Business Overview

Table 122. Dr. Reddy's Laboratories Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 123. Dr. Reddy's Laboratories Risperidone Product

Table 124. Dr. Reddy's Laboratories Recent Developments/Updates

Table 125. Torrent Pharmaceuticals Company Information

Table 126. Torrent Pharmaceuticals Description and Business Overview

Table 127. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 128. Torrent Pharmaceuticals Risperidone Product

Table 129. Torrent Pharmaceuticals Recent Developments/Updates

Table 130. Luye Pharma Group Company Information

Table 131. Luye Pharma Group Description and Business Overview

Table 132. Luye Pharma Group Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 133. Luye Pharma Group Risperidone Product

Table 134. Luye Pharma Group Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Risperidone Distributors List

Table 138. Risperidone Customers List

Table 139. Risperidone Market Trends

Table 140. Risperidone Market Drivers

Table 141. Risperidone Market Challenges

Table 142. Risperidone Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Risperidone

Figure 2. Global Risperidone Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Risperidone Market Share by Type: 2024 & 2031

Figure 4. Tablet Product Picture

Figure 5. Oral Solution Product Picture

Figure 6. Global Risperidone Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Risperidone Market Share by Application: 2024 & 2031

Figure 8. Schizophrenia

Figure 9. Bipolar Disorder

Figure 10. Global Risperidone Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Risperidone Market Size (2020-2031) & (US$ Million)

Figure 12. Global Risperidone Sales (2020-2031) & (K Pcs)

Figure 13. Global Risperidone Average Price (USD/Pcs) & (2020-2031)

Figure 14. Risperidone Report Years Considered

Figure 15. Risperidone Sales Share by Manufacturers in 2024

Figure 16. Global Risperidone Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Risperidone Players: Market Share by Revenue in Risperidone in 2024

Figure 18. Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Risperidone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Risperidone Sales Market Share by Country (2020-2031)

Figure 21. North America Risperidone Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Risperidone Sales Market Share by Country (2020-2031)

Figure 25. Europe Risperidone Revenue Market Share by Country (2020-2031)

Figure 26. Germany Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Risperidone Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Risperidone Revenue Market Share by Region (2020-2031)

Figure 33. China Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Risperidone Sales Market Share by Country (2020-2031)

Figure 43. Latin America Risperidone Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Risperidone Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Risperidone Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Risperidone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Risperidone by Type (2020-2031)

Figure 53. Global Revenue Market Share of Risperidone by Type (2020-2031)

Figure 54. Global Risperidone Price (USD/Pcs) by Type (2020-2031)

Figure 55. Global Sales Market Share of Risperidone by Application (2020-2031)

Figure 56. Global Revenue Market Share of Risperidone by Application (2020-2031)

Figure 57. Global Risperidone Price (USD/Pcs) by Application (2020-2031)

Figure 58. Risperidone Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Risperidone Microspheres for Injection Market Research Report 2024

Global Risperidone Oral Tablets Market Research Report 2024

Global Olanzapine Tablets Market Research Report 2024

Global Lurasidone Market Research Report 2024

Antipsychotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Risperdal Market Research Report 2025

Global Quetiapine Fumarate Tablets Market Research Report 2024

Global Antipsychotic Medications Market Research Report 2024

Global Lurasidone Hydrochloride Tablets Market Research Report 2024

Global Quetiapine Fumarate Market Insights Forecast to 2030

Global Ziprasidone Drugs Market Research Report 2024

Global Aripiprazole Drug Market Insights Forecast to 2030

Pharmaceutical Grade Ziprasidone Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Paliperidone Palmitate Injection Market Research Report 2024

Global Iloperidone Reagent Market Research Report 2024

Global Atypical Antipsychotic Drugs Market Insights Forecast to 2030

Global Long acting Injectable Antipsychotics LAIs Market Research Report 2024

Trifluoperazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Risperidone Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions